pristanic acid has been researched along with inositol 1,4,5-trisphosphate in 1 studies
| Studies (pristanic acid) | Trials (pristanic acid) | Recent Studies (post-2010) (pristanic acid) | Studies (inositol 1,4,5-trisphosphate) | Trials (inositol 1,4,5-trisphosphate) | Recent Studies (post-2010) (inositol 1,4,5-trisphosphate) |
|---|---|---|---|---|---|
| 103 | 2 | 17 | 6,600 | 1 | 589 |
| Protein | Taxonomy | pristanic acid (IC50) | inositol 1,4,5-trisphosphate (IC50) |
|---|---|---|---|
| Inositol-trisphosphate 3-kinase A | Rattus norvegicus (Norway rat) | 4.45 | |
| Inositol 1,4,5-trisphosphate receptor type 2 | Homo sapiens (human) | 0.03 | |
| Inositol 1,4,5-trisphosphate receptor type 3 | Homo sapiens (human) | 0.03 | |
| Inositol 1,4,5-trisphosphate receptor type 1 | Homo sapiens (human) | 0.03 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kruska, N; Reiser, G | 1 |
1 other study(ies) available for pristanic acid and inositol 1,4,5-trisphosphate
| Article | Year |
|---|---|
Phytanic acid and pristanic acid, branched-chain fatty acids associated with Refsum disease and other inherited peroxisomal disorders, mediate intracellular Ca2+ signaling through activation of free fatty acid receptor GPR40.
Topics: Calcium Signaling; Cell Line, Tumor; Fatty Acids; Fatty Acids, Nonesterified; HEK293 Cells; Humans; Inositol 1,4,5-Trisphosphate; Intracellular Fluid; Linoleic Acid; Lipid Metabolism; Methylamines; Phytanic Acid; Propionates; Receptors, G-Protein-Coupled; Refsum Disease | 2011 |